Chronic Kidney Disease is when the kidneys gradually get damaged over time and the kidneys are unable to complete functions such as removing wastes from your body, maintain blood pressure, and keeping your bones healthy.
AMCP's Tom Casey Gives a Recap of House Committee Hearing on PBMs
On July 23, 2024, the House Committee on Oversight and Accountability held a hearing, “The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part III: Transparency and Accountability.” Called to testify were:
· Adam Kautzner, PharmD, President, Express Scripts
· David Joyner, Executive Vice President, CVS Health and President, CVS Caremark
· Dr. Patrick Conway, CEO, Optum Rx
AMCP Manager of Government Affairs Tom Casey attended the hearing and in this short video shares key findings, the themes presented by those testifying, and his thoughts on the Committee’s path forward.
Learn more about AMCP's legislative priorities.
Related
Prescription Digital Therapeutics (PDTs) offer vast opportunities but require careful consideration for coverage and reimbursement. At the direction of the AMCP Board of Directors we have developed definitions and principles to simplify your decision-making and provide digital health innovators with essential insights for evaluating safety and efficacy.
The United States Pharmacopeia Convention (USP) and the United States Food and Drug Administration (FDA) have updated an educational resource on biosimilars to help healthcare practitioners improve patient confidence in the quality and effectiveness of these treatment options. The following are recommended social media, website, and email content you can use to share this resource with your network.
Featured News & Resources
See Full Calendar
Other Events
HBCU Travel Awards for AMCP25
Other Events
Mid-South AMCP Day of Education 2025
Other Events
Southwest AMCP Annual Day of Education 2025
Upcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
